PA8481701A1 - Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides - Google Patents
Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroidesInfo
- Publication number
- PA8481701A1 PA8481701A1 PA19998481701A PA8481701A PA8481701A1 PA 8481701 A1 PA8481701 A1 PA 8481701A1 PA 19998481701 A PA19998481701 A PA 19998481701A PA 8481701 A PA8481701 A PA 8481701A PA 8481701 A1 PA8481701 A1 PA 8481701A1
- Authority
- PA
- Panama
- Prior art keywords
- methods
- compositions
- otitis media
- corticosteroids
- related disorders
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010033078 Otitis media Diseases 0.000 title abstract 2
- 229960001334 corticosteroids Drugs 0.000 title abstract 2
- 201000009890 sinusitis Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 229960004123 mometasone furoate monohydrate Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN DESCRIBE COMPOSICIONES QUE EXCLUYEN ANTIBIÓTICOS Y MÉTODOS PARA TRATAR SINUSITIS Y/O OTITIS MEDIA NO INFECCIOSAS. LAS COMPOSICIONES COMPRENDEN UNA CANTIDAD TERAPÉUTICAMENTE EFICAZ DE UN CORTICOSTEROIDE, Y LOS MÉTODOS COMPRENDEN ADMINISTRAR UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UNA CANTIDAD TERAPÉUTICAMENTE EFICAZ DE UN CORTICOSTEROIDE. LOS CORTICOSTEROIDES PREFERIDOS SON FUROATO DE MOMETASONA Y MONOHIDRATO DE FUROATO DE MOMETASONA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15084798A | 1998-09-10 | 1998-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8481701A1 true PA8481701A1 (es) | 2000-09-29 |
Family
ID=22536243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA19998481701A PA8481701A1 (es) | 1998-09-10 | 1999-09-09 | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR022084A1 (es) |
| AU (1) | AU6018999A (es) |
| CO (1) | CO5160268A1 (es) |
| MY (1) | MY133181A (es) |
| PA (1) | PA8481701A1 (es) |
| PE (1) | PE20001051A1 (es) |
| TW (1) | TW589185B (es) |
| WO (1) | WO2000015234A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| PE20060489A1 (es) * | 2004-08-13 | 2006-06-19 | Schering Plough Ltd | Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061729A (en) * | 1988-06-08 | 1991-10-29 | Biogal Gyogyszergyar | Pharmaceutical composition and process for preparing the same |
| HU213401B (en) * | 1990-09-10 | 1997-06-30 | Schering Corp | Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
-
1999
- 1999-08-16 MY MYPI99003509A patent/MY133181A/en unknown
- 1999-09-09 PE PE1999000910A patent/PE20001051A1/es not_active Application Discontinuation
- 1999-09-09 TW TW088115545A patent/TW589185B/zh not_active IP Right Cessation
- 1999-09-09 AR ARP990104541A patent/AR022084A1/es unknown
- 1999-09-09 CO CO99057225A patent/CO5160268A1/es unknown
- 1999-09-09 WO PCT/US1999/018840 patent/WO2000015234A1/en active Application Filing
- 1999-09-09 AU AU60189/99A patent/AU6018999A/en not_active Abandoned
- 1999-09-09 PA PA19998481701A patent/PA8481701A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5160268A1 (es) | 2002-05-30 |
| TW589185B (en) | 2004-06-01 |
| AU6018999A (en) | 2000-04-03 |
| WO2000015234A1 (en) | 2000-03-23 |
| PE20001051A1 (es) | 2000-10-17 |
| MY133181A (en) | 2007-10-31 |
| AR022084A1 (es) | 2002-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| CL2004001170A1 (es) | Combinacion farmaceutica inhalable que contiene (a) formoterol, o una sal, o un solvato de el o de la sal y (b) furoato de mometasona; estuche farmaceutico que la comprende; y su uso en la terapia de una enfermedad inflamatoria u obstructiva de las v | |
| BR9812753A (pt) | Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica | |
| BR0008922A (pt) | Compostos úteis como agentes antiinflamatórios | |
| CY1115759T1 (el) | Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου | |
| ES2146300T3 (es) | Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos. | |
| AU2003256755A1 (en) | Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations | |
| EP2409569A3 (en) | Method for administering GLP-1 molecules | |
| DE602004032522D1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
| CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
| MX9704037A (es) | 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos. | |
| BRPI0412919A (pt) | combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos | |
| MX2022000646A (es) | Derivados de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-4 ,5,6,7- tetrahidrobenzofuran-2-sulfonamida y compuestos relacionados como moduladores de nlpr3 para el tratamiento de esclerosis múltiple (ms). | |
| BRPI0411864A (pt) | combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
| DE69838882D1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| PT1282418E (pt) | Utilizacao de derivados pirazolo para o tratamento da infertilidade | |
| CO4230161A1 (es) | Compuestos neuroprotectores que bloquean los receptores de aminoacidos excitativos y antiisquemicos | |
| PA8481701A1 (es) | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides | |
| RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
| ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
| DE60311665D1 (de) | Pharmazeutische zusammensetzungen | |
| ECSP993130A (es) | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides (caso alo916) | |
| BRPI0408113A (pt) | métodos para tratar ou prevenir um distúrbio do sistema nervoso central, para controlar um distúrbio do sistema nervoso central e para reduzir ou evitar um efeito adverso associado com a administração de um ingrediente ativo secundário em um paciente que sofre de um distúrbio do sistema nervoso central, e, composição farmacêutica |